nalirifox as frontline therapy for pdac
Published 4 years ago • 99 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
0:40
1l nalirifox in advanced or metastatic pdac
-
0:52
neo-nal-iri: liposomal irinotecan 5-fu & oxaliplatin in panceratic cancer
-
1:15
optimizing first line treatment in metastatic pancreatic cancer
-
0:54
napoli-3: first-line nalirifox in metastatic pancreatic ductal adenocarcinoma
-
6:20
first-line nalirifox shows improvement in os and pfs in metastatic pancreatic cancer
-
1:12
supporting ngs for pancreatic ductal adenocarcinoma
-
4:36
phase i/ii results: first-line nalirifox in patients with pancreatic ductal adenocarcinoma
-
0:26
fda approves new treatment for pancreatic cancer
-
5:32
potential novel target for pdac (pancreatic ductal adenocarcinoma) #code: 484
-
19:44
targeted therapy for pancreatic ductal adenocarcinoma
-
2:57
frontline options for the treatment of pancreatic cancer
-
3:31
cost effectiveness of frontline therapies for metastatic pancreatic cancer
-
6:10
therapeutic targets for tumor microenvironment (tme) of pancreatic cancer (pdac) #code: 565
-
1:42
an option for pancreatic cancer
-
3:16
a novel combination therapy for pancreatic ductal adenocarcinoma - dr scott gerber
-
19:23
new approaches in metastatic pancreatic cancer
-
0:52
dr. cohn on frontline therapies in metastatic pancreatic cancer
-
3:37
olaparib in metastatic pancreatic cancer, the polo trial
-
1:12:13
approach to neoadjuvant treated pancreatic ductal adenocarcinoma - dr. wang